It is time that pharma and payers start working together to find win-win solutions that balance the needs of pharmaceutical companies, payers and society.
In this paper, we provide a framework to help pharma and payers start a new dialogue and explore where they might find common ground. It provides answers to questions such as: What are the variables to look at and the decisions to make when deciding on a pricing scheme? How do you ensure that a pricing scheme balances the needs of pharmaceutical companies, payers and society?
Read all about it here and we are looking forward to hearing your thoughts on this topic!